Clinical Trial Update: A Trial of a Single ProHema-CB Product Transplant in Pediatric Patients With Inherited Metabolic Disorders [Phase 1]

View source ↗

Summary

Phase 1 clinical trial in pediatric patients with inherited metabolic disorders using a single ProHema-CB product transplant was terminated; results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inherited Metabolic Disorders
• Metabolic Disorders

Drugs mentioned

• ProHema CB

Snippet

Sponsor: Fate Therapeutics | Conditions: Metabolic Disorders | Phase 1 | Status: TERMINATED | Results posted: 2018-10-10